Related Experiment Video
Updated: Jul 19, 2026

09:20
In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells
Published on: July 23, 2010
15.8K
Structural analysis of human papillomavirus E6 interactions with Scribble PDZ domains
Bryce Z Stewart1, Sofia Caria1, Patrick O Humbert1,2,3
1Department of Biochemistry & Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, Australia.
The FEBS Journal
|January 7, 2023
Summary
Human papillomaviruses (HPVs) subvert cell polarity via E6 proteins targeting Scribble. This study reveals specific Scribble PDZ domains interacting with HPV E6, uncovering molecular details of this interaction and its role in cancer.
Area of Science:
- Molecular biology
- Virology
- Cancer research
Background:
- Scribble is a cell polarity regulator crucial for tissue architecture.
- Dysregulation of Scribble is linked to tumor development.
- High-risk human papillomaviruses (HPVs) target Scribble through their E6 oncoproteins.
Purpose of the Study:
- To define the molecular basis of the interaction between Scribble and HPV E6 proteins.
- To investigate which Scribble domains interact with HPV E6.
- To elucidate the structural mechanisms underlying this interaction.
Main Methods:
- Co-immunoprecipitation assays to identify Scribble-E6 interactors.
- X-ray crystallography to determine the structures of Scribble PDZ domains in complex with HPV E6 PDZ-binding motifs (PBMs).
Main Results:
- Scribble PDZ1 and PDZ3 domains are the primary interaction sites for high-risk HPV E6 proteins.
- Unique interaction profiles were observed for E6 proteins from different HPV strains.
- Crystal structures revealed distinct binding patterns between E6 PBMs and Scribble PDZ domains.
Conclusions:
- The interaction between Scribble and HPV E6 is complex and involves specific PDZ domain engagement.
- Distinct molecular interplay dictates Scribble-HPV E6 interaction strength and E6's carcinogenic potential.
- Understanding these interactions provides insights into HPV-driven oncogenesis.

